Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marmé D, Martiny-Baron G.

J Biol Chem. 1997 Apr 18;272(16):10382-8.

3.

Characterization of the VEGF binding site on the Flt-1 receptor.

Herley MT, Yu Y, Whitney RG, Sato JD.

Biochem Biophys Res Commun. 1999 Sep 7;262(3):731-8.

PMID:
10471394
5.

Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.

Roeckl W, Hecht D, Sztajer H, Waltenberger J, Yayon A, Weich HA.

Exp Cell Res. 1998 May 25;241(1):161-70.

PMID:
9633524
6.

Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.

Kaplan JB, Sridharan L, Zaccardi JA, Dougher-Vermazen M, Terman BI.

Growth Factors. 1997;14(4):243-56.

PMID:
9386989
8.

Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians.

Yamaguchi S, Iwata K, Shibuya M.

Biochem Biophys Res Commun. 2002 Mar 1;291(3):554-9.

PMID:
11855824
9.

Vascular endothelial growth factor and its receptors in normal human testicular tissue.

Ergün S, Kiliç N, Fiedler W, Mukhopadhyay AK.

Mol Cell Endocrinol. 1997 Jul 4;131(1):9-20.

PMID:
9256359
10.

Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.

Cunningham SA, Arrate MP, Brock TA, Waxham MN.

Biochem Biophys Res Commun. 1997 Nov 26;240(3):635-9.

PMID:
9398617
12.

Inhibition of vascular endothelial growth factor activity by transfection with the soluble FLT-1 gene.

Chen H, Ikeda U, Shimpo M, Maeda Y, Shibuya M, Ozawa K, Shimada K.

J Cardiovasc Pharmacol. 2000 Oct;36(4):498-502.

PMID:
11026652
14.

Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).

Tanaka K, Yamaguchi S, Sawano A, Shibuya M.

Jpn J Cancer Res. 1997 Sep;88(9):867-76.

PMID:
9369935
15.

Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.

Endo T, Kitajima Y, Nishikawa A, Manase K, Shibuya M, Kudo R.

Fertil Steril. 2001 Oct;76(4):762-8.

PMID:
11591411
16.
17.
18.
19.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.

Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.

Princess Takamatsu Symp. 1994;24:162-70. Review.

PMID:
8983073
20.

Supplemental Content

Support Center